LBP AM
MRNA icon

LBP AM’s Moderna MRNA Stock Holding History

LBP AM’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.5M Buy
+7,798
New +$840K 0.01% 379
2025
Q1 		– Sell
-184,606
Closed -$7.68M – 376
2024
Q4 		$7.68M Buy
184,606
+180,714
+4,643% +$8.64M 0.1% 157
2024
Q3 		$260K Buy
+3,892
New +$357K ﹤0.01% 349
2023
Q4 		– Sell
-5,516
Closed -$570K – 462
2023
Q3 		$570K Sell
5,516
-1,835
-25% -$205K 0.01% 402
2023
Q2 		$893K Sell
7,351
-167
-2% -$22.3K 0.02% 344
2023
Q1 		$1.15M Sell
7,518
-533
-7% -$87.9K 0.03% 348
2022
Q4 		$1.45M Buy
+8,051
New +$1.32M 0.04% 310

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

LBP AM's MRNA Position: Q3 2026 in Review

LBP AM opened a new position in Moderna (MRNA) in Q3 2026: 7,798 shares worth $1.5M. The stake represents 0.01% of the portfolio and ranks #379 among its holdings. This is a return to the name: LBP AM previously reported a position in MRNA as recently as Q4 2024.

LBP AM first reported a position in MRNA in Q4 2022 and has held it in 7 quarters since. The position peaked at $7.68M in Q4 2024. 585 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • LBP AM held 7,798 shares of Moderna worth $1.5M as of Q3 2026.
  • Moderna was a new LBP AM position in Q3 2026.
  • Moderna made up 0.01% of LBP AM's portfolio in Q3 2026, its #379 holding.
  • LBP AM first reported a position in Moderna in Q4 2022 and has held it in 7 quarters since.
  • LBP AM's Moderna position peaked at $7.68M in Q4 2024.
  • 585 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on LBP AM's 13F filing for Q3 2026, filed 6 Nov 2026.